Changchun BCHT Biotechnology News and Activities

Changchun BCHT Biotechnology is a company listed under the stock ticker 688276 (CN).

View the org chart displaying its 4 main executives

Most searched biographies at Changchun BCHT Biotechnology

• Da Qiang Feng, General Manager and Director
• Ji Ma, Chairman
• De Shen Zhang, Director

Create your alert
to follow the executive moves at Changchun BCHT Biotechnology.

Changchun BCHT Biotechnology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Changchun BCHT Biotechnology

Social media about Changchun BCHT Biotechnology

• Changchun BCHT Biotechnology on Wikipedia, Google News & Yahoo Finance
• Changchun BCHT Biotechnology on LinkedIn, X (Twitter) & YouTube